EXPERTISE

“Ravaxo is one of the leading Indian Pharmaceutical Manufacturer & Exporter of finished formulations. We manufacture the finest range of life saving drugs that includes Injectables, Pre filled syringes, Tablets & Capsules etc. Our state-of-the-art, WHO-GMP certified manufacturing facilities are located in the industrial town of Baddi, in the State of Himachal Pradesh, India.

We are a global exporter and currently export to more than 51 countries. We frequently export to regions like CIS, LATAM, Middle East, Africa, South Asia and many more.”

Our technology roadmap aims to drive and consolidate improvements in every process.

Various drug delivery and drug targeting systems are currently under development to improve efficacy and safety profiles. Two important drug delivery technologies at Ravaxo are:

• Nanoparticle-based drug formulation
• Liposomal formulation

These technologies have revolutionized the drug delivery field. Advantages of the new drug delivery technologies are

• Improved efficacy
• Reduced harmful side effects
• Increased drug bioavailability
• Targeted delivery

• Anti-cancer drugs
• Antibiotics

• Aminoglycosides
• Doxorubicin
• Amphotericin B

Ravaxo provides world-class expertise in lyophilization product and process development. We take pride in the consistent delivery of parenteral products as economically and rapidly as possible.

At Ravaxo, we have experts in lyophilization rigorously trained to achieve excellence.

In-house quality control laboratories, analytical research laboratories, Microbiology, and pharmacology laboratories are fully equipped with sophisticated instruments like high-performance liquid chromatography systems, gas chromatography systems, UV spectrometers, and all other required laboratory equipment.

Research and development is an essential aspect of our business strategies that provide a long-term advantage. Dedicated teams of highly qualified scientists and professionals are engaged in path-breaking research, thus generating IPR wealth. Research areas include

• Novel Drug Delivery Systems
• Safe fixed-dose combinations
• Analytical method of development
• Clinical Stability studies

A team of regulatory professionals are involved in dossier preparations for regulated and semi-regulated markets.

• WHO – Good Manufacturing Practices
• ISO 9001:2015
• MOH Iraq
• MOH Syria
• MOH Yemen
• MOH Vietnam
• MOH Cambodia
• MOH Sri Lanka
• MOH Nigeria